Literature DB >> 32354683

SimLife® technology in surgical training - a dynamic simulation model.

J Danion1, C Breque2, D Oriot3, J P Faure1, J P Richer4.   

Abstract

In initial surgical formation and continuing surgical education, simulation has become a compulsory technique. Just as becoming an airplane pilot requires skills, the acquisition of technical skills is essential to becoming a surgeon. The old apprenticeship model "I see, I do, and I teach" is no longer entirely compatible with the socio-economic constraints of the operating room, demands for guaranteeing patient safety, and the compulsory reduction in resident working hours. We propose a new surgical simulation model, using cadavers donated to science that are rendered dynamic with pulsatile vascularization and ventilation. Such models are available for simulation of both open surgery and laparoscopy. Surgery on a human body donated to science makes it possible to accurately reproduce the hand gestures characteristic of surgical procedures. Learning in an appropriate and realistic simulation context increases the level of skills acquired by residents and reduces stress and anxiety when they come to perform real procedures.
Copyright © 2020. Published by Elsevier Masson SAS.

Entities:  

Keywords:  SimLife; Surgical simulation

Mesh:

Year:  2020        PMID: 32354683     DOI: 10.1016/j.jviscsurg.2020.02.013

Source DB:  PubMed          Journal:  J Visc Surg        ISSN: 1878-7886            Impact factor:   2.043


  2 in total

1.  "Sim life model: introducing a new teaching device in endocrine surgery simulation". Author's commentary.

Authors:  G Donatini; S Bakkar; F Pattou
Journal:  Updates Surg       Date:  2022-01-30

2.  A cadaveric perfused model with antegrade arteriovenous pulsatile circulation: a new tool for teaching endovascular skills.

Authors:  Ahmad Rifahi; Robin Chastant; Catherine Forest-Nault; Elena Refet-Mollof; Aymeric Guy; Emmanuel Charbonney; Gilles Bronchti; Guillaume Febrer
Journal:  Can J Surg       Date:  2022-07-05       Impact factor: 2.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.